TSXV: ATE   CAD ${{ stocks['ATE.V'].LastPrice }}
Last updated: {{ getStockDate(stocks['ATE.V']) }} ET
OTCQB: ATBPF   USD ${{ stocks['ATBPF'].LastPrice }}
Last updated: {{ getStockDate(stocks['ATBPF']) }} ET
CAD ${{ getMCap(stocks['ATE.V']) }}M
MARKET CAP
CAD ${{ stocks['ATE.V'].YearHigh }}/${{ stocks['ATE.V'].YearLow }}
52-WEEK HIGH/LOW
{{ stocks['ATE.V'].AverageDailyVolume3Month }}
AVG. DAILY TRADING VOLUME
19%
INSIDER OWNERSHIP

Investor Presentation

Learn how Antibe is aiming to change the game in pain and inflammation medicine. Delve into our market opportunity, drug pipeline and the science that underlies our drug platform.

Last updated: February 2020

Attention

This is an external link. Click “OK” to continue.

CANCEL OK